Medical devices, healthcare technology and the business of care
510(k) clearance · K262443

Transorb Self-Gripping Resorbable Mesh (TSB1510 / TSB2020 / TSB3030 / TSB4030)

Sofradim Production · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONK262443

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-16 for Transorb™ Self-Gripping Resorbable Mesh, submitted by Sofradim Production of Trévoux, France, under 510(k) number K262443. The device is listed under the classification name Mesh, Surgical, Absorbable, Abdominal Hernia, regulation number 878.3300, with primary product code OWT and subsequent codes FTL and OOD. The listed models are TSB1510, TSB2020, TSB3030 and TSB4030.

The application was received 07/16/2026 as a traditional 510(k), reviewed by FDA rather than a third party, and was not a combination product; no predetermined change control plan was authorized. SESE means the submission was cleared as substantially equivalent to a predicate, not granted PMA approval. The public record does not state the predicate device, the indications for use, or the basis for the equivalence determination; those details would sit in the underlying review documents.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Oct 16, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262443
Regulatory pathway
510(k) premarket notification
Product code
OWT
Decision code
SESE
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Mesh, Surgical, Absorbable, Abdominal Hernia.

Product code
OWT
FDA device class
2

FDA decision timeline

  1. K262443 received

    Application receipt date recorded by FDA.

  2. K262443 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code OWT

Product / regulatory recordCompanyPathwayDecision dateSource
Davol, Inc., A Subsidiary of C.R. Bard, Inc.510(k) clearanceSep 28, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Sofradim Production

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Trévoux

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records